Methods for detecting mutations associated with hypertrophic car

Details Methods for detecting mutations associated with hypertrophic car Methods for detecting mutations associated with hypertrophic car

1994-12-12

1999-06-15

Zitomer, Stephanie W.

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

435 5, 435 912, 536 231, 536 243, 536 2431, 536 2433, C12Q 168, C12P 1934, C07H 2102, C07H 2104

Patent

active

059121211

ABSTRACT:
The invention pertains to methods for detecting the presence or absence of a mutation associated with hypertrophic cardiomyopathy (HC). The methods include providing DNA which encodes a sarcomeric thin filament protein (e.g., .alpha.-tropomyosin or cardiac troponin T) and detecting the presence or absence of a mutation in the amplified product which is associated with HC. DNA encoding an actin-associated protein, a myosin-associated protein, or a sarcomeric protein other than .beta. cardiac heavy chain can also be used in the methods of the present invention. The invention further pertains to methods for diagnosing familial HC (FHC) in a subject. These methods typically include obtaining a sample of DNA which encodes a sarcomeric thin filament protein from a subject being tested for FHC and diagnosing the subject for FHC by detecting the presence or absence of a mutation in the sarcomeric thin filament protein which causes FHC as an indication of the disease. An alternative method for diagnosing HC includes obtaining a sample of at least two sarcomeric proteins from a subject being tested for HC and diagnosing the subject for HC by detecting an abnormality in the sarcomeric proteins as an indication of the disease. Other aspects of the invention include kits useful for diagnosing HC and methods for treating HC.

REFERENCES:
patent: 4736866 (1988-04-01), Leder et al.
patent: 5046499 (1991-09-01), Berger
patent: 5240846 (1993-08-01), Collins et al.
patent: 5340728 (1994-08-01), Grosz et al.
patent: 5429923 (1995-07-01), Seidman et al.
Stratagene catalog, p. 39, 1988.
Thierfelder et al, "a-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sacromere", Cell 77:701-712, Jun. 1994.
Bonne et al., "Cardiac Myosin Binding Protein-C Gene Splice Acceptor Site Mutation is Associated With Familial Hypertrophic Cardiomyopathy," Nature Genetics, Dec. 1995, vol. 11, pp. 438-440.
Carrier et al., "Two New Mutations in the Cardiac C-Protein Gene Associated with Familial Hypertrophic CardioMyopathy are Predicted to Produce Truncated Proteins" Circulation, Oct. 15, 1996, vol. 94, No. 8, pp. 1426-1427, Abstract 2488.
Gautel et al., "Phosphorylation Switches Specific for the Cardiac Isoform of Myosin Binding Protein-C: a Modulator of Cardiac Contraction?" The EMBO Journal, vol. 14, No. 9, 1995, pp. 1952-1960.
Vikstrom et al., "Contractile Protein Mutations and Heart Disease" Current Opinion in Cell Biology, 1996, vol. 8, pp. 97-105.
Watkins et al., "Mutations In The Cardiac Myosin Binding Protein-C Gene On Chromosome 11 Causes Familial Hypertrophic Cardiomyopathy" Nature Genetics, Dec. 1995, vol. 11, pp. 434-437.
Anan, R. et al., "Prognostic Implications of Novel .beta. Cardiac Myosin Heavy Chain Gene Mutations That Cause Familial Hypertrophic Cardiomyopathy," J. Clin. Invest., vol. 93, 1-6, Jan. 1994.
Antonarakis, S.E., "Diagnosis of Genetic Disorders at the DNA Level," New England Journal of Medicine, vol. 320, No. 3, 153-163, Jan. 19, 1989.
Barrett et al., "Transgenic Animal Models of Cardiovascular Disease", Current Opinion in Biotechnology, vol. 3, 637-640, 1992.
Chelly, J. et al., "Transcription of the Dystrophin Gene in Human Muscle and Non-Muscle Tissues," Nature, vol. 333, 858-860, Jun. 30, 1988.
Cotton, R.G., "Detection of Single Base Changes in Nucleic Acids," Biochem J., vol. 263, 1-10, 1989.
Davies, M.J., "Hypertrophic cardiomyopathy: one disease or several?" British Heart Journal, vol. 63, No. 5, 263-4, May 1990.
Epstein, N.D. et al., "Differences in Clinical Expression of Hypertrophic Cardiomyopathy Associated With Two Distinct Mutations in the .beta.-Myosin Heavy Chain Gene," Circulation, vol. 86, No. 2, 345-352, Aug. 1992.
Geisterfer-Lowrance, A.A. et al., "A Molecular Basis for Familial Hypertrophic Cardiomyopathy: A .beta. Cardiac Myosin Heavy Chain Gene Missence Mutation," Cell, vol. 62, 999-1006, Sep. 7, 1990.
Green, M.R., "Pre-mRNA Splicing," Ann. Rev. Genet., vol. 20, 671-708, 1986.
Hardy, S. et al., "Characterization of muscle and non muscle Xenopus laevis tropomyosin mRNAs transcribed from the same gene," Eur. J. Biochem., vol. 202, 431-440, 1991.
Ido, E. et al., "Kinetic Studies of Human Immunodeficiency Virus Type 1 Protease and Its Active-site Hydrogen Bond Mutant A28S," Journal of Biological Chemistry, vol. 266, No. 36, 24359-24366, 1991.
Jaencike, T. et al., "The Complete Sequence of the Human .beta.-Myosin Heavy Chain Gene and a Comparative Analysis of Its Products," Genomics, vol. 8, 194-206, 1990.
Jarcho, J.A. et al., "Mapping a Gene for Familial Hypertrophic Cardiomyopathy to Chromosome 14q1," New England Journal of Medicine, vol. 321, 1372-1378, Nov. 16, 1989.
Keating, M., "Risk, Genotype, and Cardiovascular Disease," Circulation, vol. 86, No. 2, 688-690, Aug. 1992.
MacLeod, A.R. and C. Gooding, "Human hTM.alpha. Gene: Expression in Muscle and Nonmuscle," Molecular and Cellular Biology, vol. 8, 433-440, Jan. 1988.
MacRae et al., "An Evaluation of Ribonuclease Protection Assays for the Detection of -Cardiac Myosin Heavy Chain Gene Mutations", Circulation, vol. 89, No. 1, 33-35, Jan. 1994.
Madura, K. et al., "N-recognin/Ubc2 Interactions in the N-end Rule Pathway," Journal of Biological Chemistry, vol. 268, No. 16, 12046-12054, 1993.
Maron et al., "Patterns and Significance of Distribution of Left Ventricular Hypertrophy in Hypertrophic Cardiomyopathy," American Journal of Cardiology, vol. 48, 418-428, Sep. 1981.
McKenna et al., "Echocardiographic Measurement of Right Ventricular Wall Thickness in Hypertrophic Cardiomyopathy: Relation to Clinical and Prognostic Features," JACC vol. 11, No. 2, 351-8, Feb. 1988.
Mesnard et al. "Molecular Cloning and Developmental Expression of Human Cardiac Troponin T", FEB Letters, vol. 328, 139-144, Aug. 1993.
Miller, "Human Gene Therapy Comes of Age", Nature, vol. 357, 455-460, Jun. 11, 1992.
Myers, R. et al., "Detection of Single Bass Substitutions by Ribonuclease Cleavage at Mismatches in RNA: DNA Duplexes," Science, vol. 230, Dec. 13, 1985.
Oswald, M. and K. von der Helm, "Fibronectin is a non-viral substrate for the HIV protinase," FEBS, vol. 292, Nos. 1&2, 298-300, Nov. 1991.
Parker, T.G. and M.D. Schneider, "Growth Factors, Proto-Oncogenes, and Plasticity of the Cardiac Phenotype," Ann. Rev. Physiol., vol. 53, 179-200, 1991.
Prasad, G.L. et al., "A cDNA Encoding a Muscle-Type Tropomyosin Cloned From a Human Epithelial Cell Line: Identify With Human Fibroblast Tropomyosin TM1," Biochemical and Biophysical Research Communications, vol. 177, No. 3, 1068-1075, Jun. 28, 1991.
Robberson, B.L. et al., "Exon Definition May Facilitate Splice Site Selection in RNAs with Multiple Exons," Molecular and Cellular Biology, vol. 10, No. 1, 84-94, Jan. 1990.
Roberts et al., "Direct Diagnosis of Carriers of Duchenne and Becker Muscular Dystrophy by Amplification of Lymphocyte RNA," The Lancet, vol. 336, 1523-1526, 22-29 Dec. 1990.
Rosenzweig, A. et al., "Preclinical Diagnosis of Familial Hypertrophic Cardiomyopathy by Genetic Analysis of Blood Lymphocytes," New England Journal of Medicine, vol. 325, 1753-1760, Dec. 19, 1991.
Ruiz-Opazo, N. and B. Nadal-Ginard,".alpha.-Tropomyosin Gene Organization," Journal of Biological Chemistry, vol. 262, No. 10, 4755-4765, Apr. 5, 1987.
Saiki, R.K. et al., "Enyzmatic Amplification of .beta.-Globin Genomic Sequences and Restriction Site Analysis for Diagnosis of Sickle Cell Anemia," Science, vol. 230, 1350-1354, Dec. 20, 1985.
Sarkar, G. and S. Sommer, "Access to a Messenger RNA Sequence or Its Protein Product Is Not Limited by Tissue or Species Specificity," Science, vol. 244, 331-334, Apr. 21, 1989.
Seidman, C.E. and J.G. Seidman, "Mutations in Cardiac Myosin Heavy Chain Genes Cause Familial Hypertrophic Cardiomyopathy," Mol. Biol. Med., vol. 8, 159-166, 1991.
Shapiro, L. and W. McKenna, "Distribution of Left Ventricular Hypertrophy in Hypertrophic Cardiomyopathy: A Two Dimesional Echocardiographic Study," JACC, vol. 2, No. 3, 437-444, Sep. 1983.
Shoeman, R.L., et al., "Non-viral cellular substrates for human immunodeficiency virus type 1 protease," FE

Affiliated with

Also associated with

Rating

Methods for detecting mutations associated with hypertrophic car does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for detecting mutations associated with hypertrophic car, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for detecting mutations associated with hypertrophic car will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-401809